159 related articles for article (PubMed ID: 15032672)
1. Kinase chemogenomics: targeting the human kinome for target validation and drug discovery.
ter Haar E; Walters WP; Pazhanisamy S; Taslimi P; Pierce AC; Bemis GW; Salituro FG; Harbeson SL
Mini Rev Med Chem; 2004 Mar; 4(3):235-53. PubMed ID: 15032672
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening for kinase targets.
Muegge I; Enyedy IJ
Curr Med Chem; 2004 Mar; 11(6):693-707. PubMed ID: 15032724
[TBL] [Abstract][Full Text] [Related]
3. New lead generation strategies for protein kinase inhibitors - fragment based screening approaches.
Gill A
Mini Rev Med Chem; 2004 Mar; 4(3):301-11. PubMed ID: 15032676
[TBL] [Abstract][Full Text] [Related]
4. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
[TBL] [Abstract][Full Text] [Related]
5. Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.
Vieth M; Higgs RE; Robertson DH; Shapiro M; Gragg EA; Hemmerle H
Biochim Biophys Acta; 2004 Mar; 1697(1-2):243-57. PubMed ID: 15023365
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase inhibitors: insights into drug design from structure.
Noble ME; Endicott JA; Johnson LN
Science; 2004 Mar; 303(5665):1800-5. PubMed ID: 15031492
[TBL] [Abstract][Full Text] [Related]
7. Chemogenomics: structuring the drug discovery process to gene families.
Harris CJ; Stevens AP
Drug Discov Today; 2006 Oct; 11(19-20):880-8. PubMed ID: 16997137
[TBL] [Abstract][Full Text] [Related]
8. High-throughput structural biology in drug discovery: protein kinases.
Stout TJ; Foster PG; Matthews DJ
Curr Pharm Des; 2004; 10(10):1069-82. PubMed ID: 15078142
[TBL] [Abstract][Full Text] [Related]
9. The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases.
Fischer PM
Curr Med Chem; 2004 Jun; 11(12):1563-83. PubMed ID: 15180564
[TBL] [Abstract][Full Text] [Related]
10. Druggable exosites of the human kino-pocketome.
Nicola G; Kufareva I; Ilatovskiy AV; Abagyan R
J Comput Aided Mol Des; 2020 Mar; 34(3):219-230. PubMed ID: 31925639
[TBL] [Abstract][Full Text] [Related]
11. Chemogenomics knowledge-based strategies in drug discovery.
Jacoby E; Schuffenhauer A; Floersheim P
Drug News Perspect; 2003 Mar; 16(2):93-102. PubMed ID: 12792670
[TBL] [Abstract][Full Text] [Related]
12. The current status of drug discovery against the human kinome.
Eglen RM; Reisine T
Assay Drug Dev Technol; 2009 Feb; 7(1):22-43. PubMed ID: 19382888
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided selection of specificity determining positions in the human Kinome.
Moll M; Finn PW; Kavraki LE
BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):431. PubMed ID: 27556159
[TBL] [Abstract][Full Text] [Related]
14. Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches.
Gani OA; Thakkar B; Narayanan D; Alam KA; Kyomuhendo P; Rothweiler U; Tello-Franco V; Engh RA
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1605-16. PubMed ID: 26001898
[TBL] [Abstract][Full Text] [Related]
15. Novel kinase inhibitors by reshuffling ligand functionalities across the human kinome.
Vidović D; Muskal SM; Schürer SC
J Chem Inf Model; 2012 Dec; 52(12):3107-15. PubMed ID: 23121521
[TBL] [Abstract][Full Text] [Related]
16. Crystallography for protein kinase drug design: PKA and SRC case studies.
Breitenlechner CB; Bossemeyer D; Engh RA
Biochim Biophys Acta; 2005 Dec; 1754(1-2):38-49. PubMed ID: 16269279
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel class 1 phosphatidylinositide 3-kinases (PI3K) fragment inhibitors through structure-based virtual screening.
Giordanetto F; Kull B; Dellsén A
Bioorg Med Chem Lett; 2011 Jan; 21(2):829-35. PubMed ID: 21169017
[TBL] [Abstract][Full Text] [Related]
18. Structure-based chemogenomics: analysis of protein family landscapes.
Pirard B
Methods Mol Biol; 2009; 575():281-96. PubMed ID: 19727620
[TBL] [Abstract][Full Text] [Related]
19. Chemical genetic approaches to kinase drug discovery.
Gallion SL; Qian D
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):638-45. PubMed ID: 16159026
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity.
Foloppe N; Fisher LM; Howes R; Kierstan P; Potter A; Robertson AG; Surgenor AE
J Med Chem; 2005 Jun; 48(13):4332-45. PubMed ID: 15974586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
